Background There is a need for a new respiratory symptoms questionnaire for use in epidemiological research in asthma. Method A questionnaire was designed following a pilot study in 78 subjects. It contains nine questions on symptoms such as wheeze and difficulty with breathing in defined circumstances such as exercise and sleep. It was completed by 211 adults and validated by comparison with a self reported history of asthma and with bronchial hyperresponsiveness to histamine. Its short term reproducibility was measured by three repeat administrations over two weeks. Results Subjects with asthma (n = 33), particularly those having had an asthma
Background There is a need for a new respiratory symptoms questionnaire for use in epidemiological research in asthma. Method A questionnaire was designed following a pilot study in 78 subjects. It contains nine questions on symptoms such as wheeze and difficulty with breathing in defined circumstances such as exercise and sleep. It was completed by 211 adults and validated by comparison with a self reported history of asthma and with bronchial hyperresponsiveness to histamine. Its short term reproducibility was measured by three repeat administrations over two weeks. Results Subjects with asthma (n = 33), particularly those having had an asthma attack in the last year (n = 23), were more likely to report any symptom and to report a greater number of symptoms than those without asthma. The same relationship was found for bronchial hyperresponsiveness and symptoms. Either two or more, or three or more, symptoms appeared to be good indices of self reported asthma and bronchial hyperresponsiveness, or both, with a high sensitivity (65-91%) and specificity (85-96%). Reproducibility was good, with few subjects changing the number of symptoms reported by more than one symptom and none by more than four symptoms. The results compared favourably with those from questions on phlegm production from the MRC questionnaire and were better than those reported for 
Methods
Two hundred and eleven consecutive office workers from a central London office building were each studied three times during two weeks in January 1988. On the first study day, subjects answered a questionnaire about past medical history, smoking, and current respiratory symptoms. It was self administered and then checked for completeness. On the second and third study days they completed a similar but shorter questionnaire on current respiratory symptoms and on changes in health since the last study day.
The To increase expected numbers for x2 tests, those with asthma more than a year ago were grouped with those with no asthma and row groupings were as indicated by brackets: X' for heterogeneity = 77-36 (p < 0001); 2for trend = 59-14 (p K 0001). Respiratory spyptonis quiestionnaire for asthnma epidemioloD': validity and reproducibility Number of symptoms Figure 2 Agreenment (-) and repeatability ( --) of symptoms in the new questionnai; for two pairs of assessnments by number of symptoms used to define a "positive" questionnaire (as in fig 1) . The number of subjects with seven or more symptoms is small and estinmates nmay not be reliable. There is no consensus on a single best test for asthma in epidemiological studies and it is likely that the choice will remain dependent on a study's aims and size. Some studies have relied on self reported history of asthma but this is influenced by doctors' diagnostic practices'0 which may vary in time and place.
Tests of non-specific bronchial responsiveness are objective, but practical considerations may preclude their use in large studies and hyperresponsiveness alone may be too narrow a definition of asthma for research purposes." Our findings confirm that hyperresponsiveness to histamine is related to a history of asthma: 45% of subjects with a PD,0 of 8 ,umol or less gave a history of asthma in the last year but only 5% of those with a PD,0 over 8 pumol. Similar figures of 50% and 4%
have been obtained in another British study using the same inhalation test protocol.8 Our findings also confirm that the short term reproducibility of the inhalation test method originally described by Yan et al 6 is adequate for epidemiological work and our results compare favourably with those obtained by others using the same method.8 9 The questionnaire compared well both with a history of asthma and with bronchial hyperresponsiveness, suggesting that it provides a valid index of asthma for epidemiological purposes. The symptoms were associated significantly with both a history of asthma and also bronchial hyperresponsiveness, and the prevalence of both increased significantly with number of symptoms. The relationship with number of symptoms suggests that subjects with asthma experience several related but distinguishable symptoms provoked by a variety of circumstances, which accords with clinical experience. The pilot study5 had predicted a rather better relationship between number of symptoms and PD,0 than was found in this study, almost certainly because the pilot study had examined a larger number of symptoms and had used a higher dose of agonist which gave a wider range of PD,0 values. The weak relationship implies that the questionnaire would not estimate the level of responsiveness with precision, although it could be used to assign subjects to broad classes.
The new questionnaire can be used to provide a dichotomous index of "symptoms of asthma". A report of one or more symptoms was highly sensitive for a history of asthma (91%), bronchial hyperresponsiveness (90%), or either (86%), but was less specific (65-70%) (fig 1) , although such a sensitive index could have uses as a screening tool.
Two or more, and three or more, symptoms gave increased specificity for a history of asthma (85% and 92%), for bronchial hyperresponsiveness (87% and 94%), and for either (90% and 96%) without unduly compromising sensitivity (91% and 78%, 79% and 69%, 78% and 65%). These values of sensitivity and specificity should be compared with those of a symptom question whose validity is generally accepted and we have chosen the questions on sputum production in the MRC questionnaire,"'2-4 which have been reviewed by Samet.'5 The questions on sputum production, when compared with the presence of sputum in a collection bottle, had sensitivity values in the range 43-84% and specificity values in the range 75% or less to 91%. Our study suggested a sensitivity of 65-91% and a specificity of 85-96%, which compares favourably.
Our new questionnaire and two others which also ask about symptoms in defined circumstances are all more sensitive for bronchial hyperresponsiveness than the questions in the MRC questionnaire on wheeze.'-4 Mortagy et al 16 described a questionnaire about nocturnal or morning symptoms, or symptoms with environmental irritants. Combining data from their studies of 75 and 90 subjects, a report of at least one symptom in their questionnaire had a sensitivity of 35% and specificity of 95% for a histamine PC,0 of less than 8 mg/ml. These values are similar to those for four or five symptoms in our questionnaire which may suggest that our questionnaire is more sensitive for bronchial hyperresponsiveness, or may be explained by differences in inhalation test protocols. Burney et all7 used the same inhalation test protocol as in our study in 256 subjects to validate a discriminant function predictor derived from the International Union against Tuberculosis and Lung Disease (IUATLD) bronchial symptoms questionnaire. They obtained values of sensitivity (53%) and specificity (90%) which are intermediate between those in our study and that of Mortagy et al. 16 The symptoms used to derive the discriminant function predictor included shortness of breath at night and tightness in the chest in dusty parts of the house or with animals or feathers. These broadly similar results from different investigators in different populations strengthen each other.
The predictive value of a questionnaire is an important measure but depends on the prevalence of asthma in the population under study, as well as on sensitivity and specificity. Our The short term reproducibility of the questionnaire was good. Measured as agreement, the reproducibility of two or more symptoms was 94% and 98% and of three or more symptoms was 96% and 96%. This is similar to that for smoking habit'5 and better than the 78-91% reported for phlegm production.'2 20 24 Agreement is a widely used measure of reproducibility but has the drawback that it increases with decreasing prevalence of symptoms. Repeatability is a more stable estimate of reproducibility and the repeatability of this questionnaire was 76% and 88% for two or more symptoms, and 72% and 73% for three or more symptoms. This is better than the range of 38-71% reported for phlegm production. 12 2024 Our good results could be explained in part by the study's -control of observer variation and its short test to retest interval. Repeatability generally increases as the test to retest interval falls,'2 20-24 perhaps because subjects can remember previous answers more readily, but also because respiratory symptoms change less over days or weeks than they do over several months. It is important to use a short time interval in studying the reproducibility of tests intended to detect asthma because it is a condition of variable severity in which real changes occur over short periods. Our findings suggest that a change in number of symptoms in the new questionnaire of more than one or two is unusual and further suggest that change in number of symptoms reflects change in respiratory health or PD20 (table 6) . Reproducibility was slightly better between the second and third study days than between the first and second, which may suggest that a practice session could be useful in longitudinal studies.
In conclusion we, in common with others,'6 ' 1 have found that a questionnaire about respiratory symptoms in defined circumstances is a better predictor of asthma and bronchial hyperresponsiveness than the MRC wheeze questions. Our questionnaire has good short term reproducibility and may be a better discriminator of bronchial hyperresponsiveness than other questionnaires.'617 Questionnaires for asthma epidemiology are now at the same stage as those for bronchitis research in the 1950s. We recommend that interested organisations such as the MRC and IUATLD should bring together the groups that are working on these questionnaires.
[ Tables summarising published information on the validity and reproducibility of the questions on sputum production from the MRC questionnaire are available from the authors.]
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